Gastrointestinal Sensorimotor Dysfunctions in Diabetes Mellitus
Completed · Phase 2 · Has a placebo group
Conditions studied: Dyspepsia, Diabetes Mellitus With Gastrointestinal Symptoms
In brief
The purpose of this study is to understand why people with indigestion have gastrointestinal symptoms and in particular to understand whether symptoms are related to increased sensitivity to nutrients in the small intestine and to a hormone (GLP1) which is normally released from the small intestine in response to nutrients. We propose to study the contribution of GLP1 to intestinal sensitivity with a drug (exendin 9-39) that blocks the effects of GLP1.
Key facts
- Study ID
- NCT02170870
- Run by
- Mayo Clinic
- People needed
- 104
- Starts
- 2014-06-01
- Expected to finish
- 2017-11-17
- Last updated by the study team
- 2019-04-23
Who can join
Age: 18 and older, up to 70. Sex: any. Healthy volunteers: accepted.
Where it is running
- Mayo Clinic in Rochester — Rochester, Minnesota, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.